145 related articles for article (PubMed ID: 16630234)
21. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
22. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview.
Ooi BS; Tjandra JJ; Green MD
Dis Colon Rectum; 1999 Mar; 42(3):403-18. PubMed ID: 10223765
[TBL] [Abstract][Full Text] [Related]
23. Rectal cancer radiotherapy: towards European consensus.
Valentini V; Glimelius B
Acta Oncol; 2010 Nov; 49(8):1206-16. PubMed ID: 20843179
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting anastomotic complications following anterior resection in rectal cancer.
Lyall A; Mc Adam TK; Townend J; Loudon MA
Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
[TBL] [Abstract][Full Text] [Related]
25. Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results.
Muratore A; Mellano A; Marsanic P; De Simone M
Eur J Surg Oncol; 2015 Apr; 41(4):478-83. PubMed ID: 25633642
[TBL] [Abstract][Full Text] [Related]
26. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
27. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
[TBL] [Abstract][Full Text] [Related]
30. The impact of pre- or postoperative radiochemotherapy on complication following anterior resection with en bloc excision of female genitalia for T4 rectal cancer.
Szynglarewicz B; Matkowski R; Gisterek I; Forgacz J; Lacko A; Pudelko M; Kornafel J
Colorectal Dis; 2009 May; 11(4):377-81. PubMed ID: 18637920
[TBL] [Abstract][Full Text] [Related]
31. Impaired anastomotic healing after preoperative radiotherapy followed by anterior resection for treatment of rectal carcinoma.
Vermeulen J; Lange JF; van der Harst E
S Afr J Surg; 2006 Feb; 44(1):12, 14-6. PubMed ID: 16619985
[TBL] [Abstract][Full Text] [Related]
32. Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients.
van den Broek CB; Vermeer TA; Bastiaannet E; Rutten HJ; van de Velde CJ; Marijnen CA
Eur J Cancer; 2013 Oct; 49(15):3131-9. PubMed ID: 23800669
[TBL] [Abstract][Full Text] [Related]
33. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.
Chen TY; Wiltink LM; Nout RA; Meershoek-Klein Kranenbarg E; Laurberg S; Marijnen CA; van de Velde CJ
Clin Colorectal Cancer; 2015 Jun; 14(2):106-14. PubMed ID: 25677122
[TBL] [Abstract][Full Text] [Related]
34. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision.
Lezoche E; Guerrieri M; Paganini AM; Feliciotti F
World J Surg; 2002 Sep; 26(9):1170-4. PubMed ID: 12209248
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
[TBL] [Abstract][Full Text] [Related]
37. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
38. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
39. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
Gietelink L; Wouters MWJM; Marijnen CAM; van Groningen J; van Leersum N; Beets-Tan RGH; Tollenaar RAEM; Tanis PJ;
Eur J Surg Oncol; 2017 Jul; 43(7):1297-1303. PubMed ID: 28351504
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer.
Sclafani F; Cunningham D
Future Oncol; 2014 Nov; 10(14):2243-57. PubMed ID: 25471037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
